Home
Storia in 1 fonti
Bristol-Myers Boosts 2026 Guidance on Portfolio Strength - Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers beats Q2 earnings and revenue estimates, driven by growth drugs, while raising its full-year 2026 sales and profit outlook.
Raccontata da
benzinga.com
Timeline cronologica
- ·
How To Earn $500 A Month From Bristol-Myers Squibb Stock Ahead Of Q2 Earnings - Bristol-Myers Squibb (NYS
BMY to release Q2 earnings on 7/30. Analysts expect $1.60 EPS and $11.74B revenue. Dividend yield is 3.96%. To earn $500 monthly, investor needs $151,432 worth of BMY or 2,381…
- ·
Bristol-Myers Boosts 2026 Guidance on Portfolio Strength - Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers beats Q2 earnings and revenue estimates, driven by growth drugs, while raising its full-year 2026 sales and profit outlook.